Joseph Woodard

Institution Name: 
Immune-Onc Therapeutics
Total Awards: 
1
Award Value: 
$6,000,000
  • Share
  • Print
  • PDF version

Awards as PI

Program Type Institution Grant Title Award Value
Clinical Trial Stage Projects Immune-Onc Therapeutics Phase 1 Clinical Development of IO-202, A First-in-Class Antibody Targeting LILRB4, for the Treatment of AML with Monocytic Differentiation and CMML $6,000,000
Total:
$6,000,000.00